Evidence map›Paper›PMID 37292864›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Influence of vitamin D supplementation on fracture risk, bone mineral density and bone biochemistry in Mongolian schoolchildren: multicenter double-blind randomized placebo-controlled trial.

Davaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, Enkhtsetseg Tserenkhuu, Sumiya Erdenenbaatar, Chuluun-Erdene Achtai, Narankhuu Yansan, Baigal Delgererekh, Munkhzaya Ankhbat, Enkhjargal Tsendjav and 4 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Davaasambuu GanmaaChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Polyna KhudyakovSage Therapeutics, Cambridge, MA, USA.
Uyanga BuyanjargalMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar 13312, Mongolia.
Enkhtsetseg TserenkhuuGlobal Laboratory, Royal Plaza, Bayanzurkh District, Ulaanbaatar 13312, Mongolia.
Sumiya ErdenenbaatarMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar 13312, Mongolia.
Chuluun-Erdene AchtaiMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar 13312, Mongolia.
Narankhuu YansanMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar 13312, Mongolia.
Baigal DelgererekhGlobal Laboratory, Royal Plaza, Bayanzurkh District, Ulaanbaatar 13312, Mongolia.
Munkhzaya AnkhbatGlobal Laboratory, Royal Plaza, Bayanzurkh District, Ulaanbaatar 13312, Mongolia.
Enkhjargal TsendjavMongolian Health Initiative, Royal Plaza, Bayanzurkh District, Ulaanbaatar 13312, Mongolia.
Batbayar OchirbatNational Center for Communicable Disease, Bayanzurkh District, Ulaanbaatar 13312, Mongolia.
Badamtsetseg JargalsaikhanMongolian National University of Medical Sciences, Sukhbaatar District, Ulaanbaatar 14210, Mongolia.
Enkhmaa DavaasambuuNational Center for Maternal and Child Health, Bayangol District, Ulaanbaatar 16060, Mongolia.
Adrian R MartineauBlizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
National Center for Communicable Diseases · MNBrigham and Women's Hospital · USMongolian National University of Medical Sciences · MNQueen Mary University of London · GBSage Therapeutics (United States) · US

Funding

Trial of Vitamin D Supplementation to Prevent TB Infection in SchoolchildrenR01HL122624 · NHLBI · HARVARD SCHOOL OF PUBLIC HEALTH · PI DAVAASAMBUU, GANMAA · 2014 to 2018
$3.5M
NHLBI NIH HHS R01 HL122624
6 · The paper itself

Abstract

Background: Randomized controlled trials (RCT) of vitamin D supplementation to reduce fracture risk in children are lacking. Methods: We conducted a Phase 3 RCT of weekly oral supplementation with 14,000 IU vitamin D Findings: 8851 children were enrolled in the main trial, of whom 1465 also participated in the sub-study. Vitamin D deficiency was prevalent at baseline (25[OH]D <20 ng/mL in 90.1%). The intervention elevated 25(OH)D concentrations (adjusted inter-arm mean difference [aMD] 20.3 ng/mL, 95% CI 19.9 to 20.6) and suppressed PTH concentrations (aMD -13.6 pmol/L, 95% CI -23.5 to -3.7), but it did not influence fracture risk (adjusted risk ratio 1.10, 95% CI 0.93 to 1.29, P=0.27) or radial BMD z-score (aMD -0.06, 95% CI -0.18 to 0.07, P=0.36). Vitamin D suppressed serum BALP concentrations more among participants with baseline 25(OH)D concentrations <10 vs. ≥10 ng/mL (P Interpretation: Weekly oral vitamin D supplementation elevated serum 25(OH)D concentrations and suppressed PTH concentrations in vitamin D-deficient schoolchildren in Mongolia. However, this was not associated with reduced fracture risk or increased radial BMD. Funding: National Institutes of Health.

Identifiers

PMID37292864
PMCPMC10246036
OpenAlexW4377088635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.